|
26.10.2018 08:12:00
|
Medicover - Interim Report July-September 2018
STOCKHOLM, Oct. 26, 2018 /PRNewswire/ --
Third Quarter
- Revenue increased by 16.3% to €167.4m (€144.0m). Organic revenue grew by 13.8%.
- Operating profit amounted to €7.4m (€8.5m), representing an operating margin of 4.4% (5.9%).
- Net profit amounted to €6.2m (€4.3m), which represents a net profit margin of 3.7% (3.0%).
- Cash flow from operating activities amounted to €21.8m (€15.3m).
- Basic/diluted earnings per share (EPS) were €0.042 (€0.030).
- EBITDA increased by 0.7% to €15.1m (€15.0m), corresponding to an EBITDA margin of 9.0% (10.4%).
Nine Months
- Revenue increased by 14.7% to €490.4m (€427.5m). Organic revenue grew by 13.9%.
- Net profit amounted to €22.6m (€11.0m), which represents a net profit margin of 4.6% (2.6%).
- EBITDA increased by 7.9% to €43.6m (€40.4m), corresponding to an EBITDA margin of 8.9% (9.5%)
REVENUE AND EARNINGS
€ millions (€m) |
Q3 2018 |
Q3 2017 |
Growth |
9M 2018 |
9M 2017 |
Growth | FY 2017 |
Revenue |
167.4 |
144.0 |
16% |
490.4 |
427.5 |
15% |
580.2 |
Operating profit |
7.4 |
8.5 |
-13% |
21.9 |
21.0 |
4% |
28.8 |
Operating profit margin, % |
4.4% |
5.9% |
4.5% |
4.9% |
5.0% | ||
Net profit |
6.2 |
4.3 |
44% |
22.6 |
11.0 |
105% |
20.2 |
Net profit margin, % |
3.7% |
3.0% |
4.6% |
2.6% |
3.5% | ||
Earnings per share, € |
0.042 |
0.030 |
40% |
0.159 |
0.085 |
87% |
0.157 |
Diluted earnings per share, € |
0.042 |
0.030 |
40% |
0.159 |
0.085 |
87% |
0.157 |
EBITDA |
15.1 |
15.0 |
1% |
43.6 |
40.4 |
8% |
55.0 |
EBITDA margin, % |
9.0% |
10.4% |
8.9% |
9.5% | 9.5% |
For Alternative Performance Measure definitions and reconciliations, refer to note 8
Contact information
For further information, please contact:
Paula Treutiger, Director Corporate Communications & Investor Relations
Phone: +46-73-366-65-99
E-mail: paula.treutiger@medicover.com
This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 (CEST) on 26 October 2018. This interim report and other information about Medicover, is available at medicover.com.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenue around €580 million and 15,900 employees. For more information, go to www.medicover.com.
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/medicover/r/interim-report-july-september-2018,c2655072
The following files are available for download:
Interim report July-September |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medicover AB Registered Shs -B-mehr Nachrichten
|
29.10.24 |
Ausblick: Medicover Registered B präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
|
15.10.24 |
Erste Schätzungen: Medicover Registered B gewährt Anlegern Blick in die Bücher (finanzen.net) | |
|
24.07.24 |
Ausblick: Medicover Registered B verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
|
10.07.24 |
Erste Schätzungen: Medicover Registered B stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Medicover AB Registered Shs -B-mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.